Free Trial

Ardent Health Partners (ARDT) Stock Price, News & Analysis

Ardent Health Partners logo
$13.62 -0.58 (-4.10%)
As of 11:26 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Ardent Health Partners Stock (NYSE:ARDT)

Key Stats

Today's Range
$13.62
$14.38
50-Day Range
$13.75
$17.08
52-Week Range
$13.55
$20.72
Volume
77,137 shs
Average Volume
384,116 shs
Market Capitalization
$1.94 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.18
Consensus Rating
Buy

Company Overview

Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

Remove Ads
Receive ARDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ardent Health Partners and its competitors with MarketBeat's FREE daily newsletter.

ARDT Stock News Headlines

Healthcare text surrounded by medical equipment: assistance and concept
3 Beaten Down Healthcare Stocks Recovering in 2025 (ARDT)
Healthcare stocks took a tumble in 2024 as rising medical costs did a number on margins and profitability, but 2025 may be the year they rebound.
Elon Musk’s Final Move REVEALED
Elon's new AI firm is not traded publicly. So everyday Americans have no chance to invest. But we've uncovered a "backdoor" way to invest - for as little as $100.
Ardent Health price target lowered to $21 from $23 at RBC Capital
See More Headlines

ARDT Stock Analysis - Frequently Asked Questions

Ardent Health Partners' stock was trading at $17.08 at the beginning of the year. Since then, ARDT shares have decreased by 20.0% and is now trading at $13.67.
View the best growth stocks for 2025 here
.

Ardent Health Partners, LLC (NYSE:ARDT) released its quarterly earnings data on Wednesday, February, 26th. The company reported $0.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.31. The company had revenue of $1.61 billion for the quarter, compared to analysts' expectations of $1.48 billion.

Ardent Health Partners (ARDT) raised $192 million in an IPO on Thursday, July 18th 2024. The company issued 12,000,000 shares at a price of $16.00 per share.

Ardent Health Partners' lock-up period expired on Tuesday, January 14th. Ardent Health Partners had issued 12,000,000 shares in its IPO on July 18th. The total size of the offering was $192,000,000 based on an initial share price of $16.00. Since the expiration of Ardent Health Partners' lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company have been lifted.

Top institutional shareholders of Ardent Health Partners include Ventas Inc. (6.55%), Point72 Asset Management L.P. (1.13%), Wellington Management Group LLP (1.09%) and Franklin Resources Inc. (0.64%).

Shares of ARDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ardent Health Partners investors own include Broadcom (AVGO), 4D Molecular Therapeutics (FDMT), Mirum Pharmaceuticals (MIRM), Micron Technology (MU), Uber Technologies (UBER), Advanced Micro Devices (AMD) and ASML (ASML).

Company Calendar

Last Earnings
2/26/2025
Today
3/12/2025
Next Earnings (Estimated)
5/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
General medical & surgical hospitals
Sub-Industry
Healthcare
Current Symbol
NYSE:ARDT
Previous Symbol
NYSE:ARDT
Web
N/A
Fax
N/A
Employees
24,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$21.18
High Stock Price Target
$25.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+49.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
12 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.97 billion
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$2.03 billion
Optionable
Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NYSE:ARDT) was last updated on 3/12/2025 by MarketBeat.com Staff
From Our Partners